Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Nasogastric Tube Market size is set to expand from USD 561.98 million in 2024 to USD 1.11 billion by 2037, exhibiting a CAGR of more than 5.4% during the forecast timeline, between 2025 and 2037. Currently in 2025, the industry revenue of nasogastric tube is evaluated at USD 583.22 million.
The growth of the market will rise owing to a higher count of surgical procedures being carried out. On an annual basis, millions of people get surgical treatment, with surgical treatments accounting for an estimated 13% of total disability-adjusted life years worldwide. During surgery, a nasogastric tube is inserted to remove accumulated air, fluid, or gastrointestinal contents from the stomach.
Furthermore, the number of malnourished people will increase the demand for nasogastric tubes. Nasogastric tubes ensure that essential nutrients, including protein, carbohydrates, fats, vitamins, and minerals are delivered to the body to address malnutrition and promote recovery. In 2021, almost 2.3 billion individuals which is around 29.3% of the global population were either severely or moderately lacked surviving nutrition.
Nasogastric Tube Market: Growth Drivers and Challenges
Growth Drivers
- Higher Number of ICU Admissions – The people admitted to ICU, are in severe condition and face difficulties in consuming medicines orally. Nasogastric tubes are used to administer these medicines. In the United States, total non-COVID-19 admissions had risen to 16 percent of pre-pandemic baseline volume by late June/early July 2020.
- Increasing Prevalence of Chronic Diseases–In certain chronic diseases, such as pancreatic disorders or conditions with excessive fluid accumulation in the abdomen, nasogastric tubes can be used to drain excess fluid or prevent aspiration. By draining fluid from the stomach or preventing its reflux into the lungs, nasogastric tubes can help manage symptoms, reduce the risk of complications, and improve the patient’s life. According to the American Cancer Society's projections for pancreatic cancer in the United States in 2023, around 64,050 persons are anticipated to be diagnosed.
- Higher Adoption of Enteral Feeding– Nasogastric tubes provide a relatively simple and non-invasive method for enteral feeding in the ICU. They are a temporary solution and are easier to insert. Around 20% of children under the age of 18 are tube fed in America, and there are over 350 conditions that can need children to need nourishment using tube feeding.
Challenges
- Infection Caused by the Tube – Nasogastric tubes, being invasive devices, pose a risk of infection. Improper insertion, inadequate maintenance, or prolonged use of the tube can increase the risk of infection, such as bloodstream infections, and pneumonia. Moreover, it can also cause nasal and sinus problems, such as nasal congestion, rhinitis, or sinusitis.
- Availability and Adoption of Alternative Enteral Access Methods
- Lack of Reimbursement Policies
Nasogastric Tube Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.4% |
|
Base Year Market Size (2024) |
USD 561.98 million |
|
Forecast Year Market Size (2037) |
USD 1.11 billion |
|
Regional Scope |
|
Nasogastric Tube Segmentation
Indication (Dysphagia, IBD, Unconsciousness, Neck & Head Cancer, Malnutrition)
The dysphagia segment is estimated to hold over 45% share of the global nasogastric tube market by 2037. Moreover, the segment was responsible for around 21% of the total market portion in 2022. Dysphagia is the weakening and destruction of the nerves and muscles that are required for swelling. The primary cause of dysphagia is stroke, head injury, dementia, and others. Every year, in the world 15 million people are affected by a stroke. 5 million of these people die, and another 5 million are chronically crippled. Due to dysphagia, the risk of malnutrition and dehydration. Nasogastric tubes can provide a means to deliver clinical nutrition directly into the stomach, ensuring the patient is meeting their dietary requirement.
Tube (Levin Catheter, Dobhoff Tube, Sengstaken-Blakemore Tube)
The levin catheter segment in the nasogastric tube market is expected to garner a significant proportion of around 46% in the year 2037. The growth of the segment is credited to the higher adoption of Levin tubes, which has an open tip and only a single lumen. Furthermore, improved access to healthcare services, particularly in developing regions, can contribute to an increased demand for medical procedures that necessitate the use of Levin catheters.
Our in-depth analysis of the global nasogastric tube market includes the following segments:
|
Tube |
|
|
Patient Group |
|
|
Indication |
|
|
End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportNasogastric Tube Market - Regional Synopsis
North American Market Forecast
North America industry is predicted to dominate majority revenue share of 39% by 2037. The development of various supportive regulatory guidelines by the regulatory bodies in the region that creates several investment opportunities for businesses will drive market growth. For instance, in June 2021, the U.S. FDA introduced the guideline for researching and testing oral drug consumption using the enteral feeding tube. Moreover, the growing cases of heart disease and cancer will surge the demand for nasogastric tubes. Since, these diseases require intensive unit care and surgical procedures, therefore the need for enteral feeding rises.
APAC Market Analysis
Asia Pacific nasogastric tube market is anticipated to hold a notable contribution till 2037. The region has a huge population of older adults. Between 2010 and 2050, the region's population of senior people (those over the age of 60) will triple. One in four people will be above 60 years old, reaching a total population of 1.3 billion by 2050. Due to several reasons, such as poor appetite, and medical conditions, older people face trouble in consuming adequate nutrition orally. Nasogastric tubes help in hydration and nutritional management in them.
Top Featured Companies Dominating the Nasogastric Tube Market
- Becton, Dickinson and Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- QMD
- Angiplast Pvt. Ltd.
- Securmed
- Vygon SAS
- Medtronic
- Andersen Products Ltd.
- Cardinal Health
- Baihe Medical
- Poly Medicure Limited
In the News
- QMD announced the launch of Nasogastric tubes in the portfolio of Degania Enteral Feeding Product. The material used for the manufacturing of these tubes adheres to the standards of ENFit for improving the safety of the patient, the designs are available for both babies and adults.
- Securmed announced the collaboration with Delta Med Group to expand their company in the Italian and European markets. The agreement will lead to the development of better products of high quality.
Author Credits: Radhika Pawar
- Report ID: 5016
- Published Date: Mar 20, 2025
- Report Format: PDF, PPT
